Publications

Beer P, Pauli C, Haberecker M, Grest P, Beebe E, Fuchs D, Markkanen E, Krudewig C, Nolff M. Cross species evaluation of fibroblast activation protein alpha as a potential imaging target for soft tissue sarcoma: a comparative immunohistotlogical study in humans, dogs and cats. Front. Oncol. Sec Cancer Molecular Targets and Therapeutics, Volume 13 2023.
10.3389/fonc.2023.1210004

Cieslik PA, Klingler S, Nolff M, Holland JP. Radiolabelled 177Lu-Bispidine-Trastuzumab for Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancers. Chemistry A European Journal. 2023.
https://doi.org/10.1002/chem.202303805

Beer P, Grest P, Krudewig C, Staudinger C, Ohlert S, Rohrer Bley C, Jarosch A, Ech-Charif H, Markkanen E, Parl B, Nolff MC. Evaluation of a targeted anti-αvβ3 integrin near-infrared fluorescent dye for fluorescence-guided resection of naturally occurring soft tissue sarcomas in dogs. Eur J Nucl Mol Imaging 2024.
https://doi.org/10.1007/s00259-024-06953-x

Weber M, Fuchs D, Pöschel A, Beebe E, Garajova Z, Jarosch A, Kunz L, Wolski W, Opitz L, Guscetti F, Nolff MC*, Markkanen E.* Transcriptomic and proteomic profiling identifies feline fibrosarcoma as clinically amenable model for aggressive sarcoma subtypes. Neoplasia 2024.
10.1016/j.neo.2024.101104

Genz J, Berton C, Kichou S, Klingler S, Nolff MC, Braband H, Holland JP. Photoradiolabeling of onartuzumab with 99mTc and 188Re-tricarbonyl for radiotheranostics of gastric cancer. Chemical Science 2025.
https://doi.org/10.1039/D4SC08089K

Chiti LE, Beer P, Ohlert SM, Hartnack S, Nolff MC. SHINE - Validation of near infrared fluorescence lymphography against lymphoscintigraphy for sentinel lymphnode biopsy in dogs with mast cell tumors. Veterinary Comparative Oncology.
10.1111/vco.13058